




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
Katrin
HartmannProf.,
Dr.
med.
vet.,
Dr.
habil.,
Dipl.
ECVIM-CAFeline
Stomatitis貓的口炎?Mister
Q“Siamese
暹羅貓9
years
9歲male
neutered雄性已絕育lives
in
Munich住在慕尼黑single-cat
household,only
indoors獨養(yǎng),室內(nèi)referred
for
stomatitis因口炎轉(zhuǎn)診FIV
infection
known
since
6
years
6年前查出
FIVbiopsy:
lymphoplasmocytic
stomatitis活檢:淋巴漿細胞性口炎?Mister
Q“Stomatitis口炎=
inflammation
ofthe
mucous
membranes
of
themouth=口腔黏膜的炎癥very
common很常見often
young
cats常見于青年貓often
chronic通常是慢性的often
without通常沒有牙stomatogingivitis,
gingivostomatitis,faucitis,lymphoplasmocytic
stomatitis口腔牙齦炎,齦口炎,咽喉炎淋巴漿細胞性口炎Etiology
病因primary
pathogenes?oral
microbial
flora/病原體??口腔菌群/牙chronic timulation?抗原慢性刺激immune-mediated
processes?免疫介導(dǎo)過程immune
dysregulation?免疫失調(diào)Etiology病因histology
組織學(xué):mainly
plasma
cells
and
lymphocyteswith
possible
neutrophilic
and
eosinophilicinflammation
(different
degrees)主要是漿細胞和淋巴細胞性炎癥,可能有中性粒細胞和嗜酸性粒細胞性炎癥(不同程度)circulating
lymphocytes
外周淋巴細胞?expression
von
inflammatory
cytokines炎性細胞因子表達增高=>
chronic timulation
and/ordysregulation
of
the
immune
system慢性抗原刺激和/或免疫系統(tǒng)調(diào)節(jié)異常Potential
Pathogenes
Involved潛在的病原體feline
calici貓杯狀
feline
herpes貓皰疹(FCV)(FHV)feline
immunodeficiency貓免疫缺陷(FIV)felines
leukemia
(FeLV)貓白血病Bartonella
(mainly
Bartonella
henselae)氏體(主要是漢氏氏體)other
bacteria
(e.g.,Bacteroides
spp.)其它細菌如,擬桿菌屬)Study:
Relevance
of
Pathogenes研究:相關(guān)病原體52
cats
with
chronic
stomatitis
52只慢性口炎貓stomatitis>3
weeks
口炎>3周no沒有牙or
other
dental
changes或其它口腔病變50
age-matched
control
cats50只
一致的對照貓clinically
healthy
臨床健康no
history
ofstomatitis
無口炎病史examinations
檢查生化history,
incl.
accurate
vaccination
history病史,包括精確的免疫史physical
examination
體檢blood
tests
血檢CBC
and
serum
biochemistry
血常規(guī)和antibodies
(FIV,
FCV,
Bartonella
henselae),漢氏巴)氏體)抗體檢測(貓免疫缺陷 ,
貓杯狀爾通氏體)(FeLV)
抗原檢測
(貓白血病RNA/DNA(Bartonella
henselae漢氏swabs
oftheoral
口腔拭子RNA/DNA
(FCV,
FHV,
Bartonella
henselae)Study:
Relevance
of
Pathogenes研究:相關(guān)病原體stomatitis口炎組
n=52controls對照組
n=50p*標(biāo)準(zhǔn)差FCV
swab
FCV拭子53.8
%14.0
%<
0.001FCV
AB
FCV抗體78.8%58.0
%0.024FHV
swab
FHV拭子13.5%6.0%0.320FIV
blood
FIV血液5.8%0
%0.121FeLV
blood
FeLV血9.6%0
%0.060B.
henselae
swab漢氏 氏體拭子19.2%12.0
%0.320B.
henselae
blood漢氏 氏體血液17.3%8.0%0.161B.
henselae
AB漢氏 氏體抗體9.6
%10.0
%1.000*Chi-square/‘s
exact
testStudy:
Relevance
of
Pathogenes研究:相關(guān)病原體stomatitis口炎組n
=
52controls對照組n
=
50p*標(biāo)準(zhǔn)差FCV
swab
FCV拭子53.8
%14.0
%<
0.001FCV
AB
FCV抗體78.8
%58.0
%0.024FHV
swab
FHV拭子13.5
%6.0%0.320FIV
blood
FIV血液5.8
%0
%0.121FeLV
blood
FeLV血9.6
%0
%0.060B.
henselae
swab漢氏 氏體拭子19.2
%12.0
%0.320B.
henselae
blood漢氏 氏體血液17.3
%8.0%0.161B.henselae
AB漢氏 氏體抗體9.6
%10.0
%1.000*Chi-square/‘s
exact
testStudy:
Relevance
of
Pathogenes研究:相關(guān)病原體stomatitis口炎組n
=
52controls對照組n
=
50p*標(biāo)準(zhǔn)差FCV
swab
FCV拭子53.8
%14.0%<0,001ODDs
ratio比值比(OR)confidence
interval置信區(qū)間7,12.5
<
OR
<
21.3FCV
AB
FCV抗體78.8
%58.0%0,024ODDs
ratio比值比confidence
interval置信區(qū)間2,71.0
<
OR
<
7.1*Chi-square/‘s
exact
testStudy:
Relevance
of
Pathogenes研究:相關(guān)病原體stomatitis口炎組n
=
52controls
對照組n
=
50p*標(biāo)準(zhǔn)差roam
outside
流浪貓42,3
%56,0
%0,173multi-cat
househ.家里飼養(yǎng)多只貓56,3
%63,4
%0,491%male
%雄性59,6
%58,0
%0,870%DSH
%本地短毛貓78,8
%92,0
%0,063vaccination
免疫48,1
%44,0
%0,784agemedian
中值mean
平均值5,0
years6,0
years5,0
years6,1
years0,911*Chi-square/‘s
exact
testStudy:
Relevance
of
Pathogenes研究:相關(guān)病原體Potential
Pathogenes
Involved潛在的相關(guān)病原體pfeline
calicifeline
herpes(FCV)
貓杯狀
(FCV)(FHV)
貓皰疹feline
immunodeficiency
(FIV)貓免疫缺陷felines
leukemia (FeLV)貓白血病Bartonella
(mainly
Bartonella
henselae)氏體(主要是漢氏
氏體)other
bacteria
(e.g.,
Bacteroides
s其它細菌(如,擬桿菌屬)Feline
Calici貓杯狀(FCV)(FCV)Etiology
病因
Symptoms
癥狀
DiagnosisTreatment
治療
Prophylaxis
預(yù)防Feline
Calici貓杯狀(FCV)(FCV)Etiology
病因
Symptoms
癥狀
DiagnosisTreatment
治療
Prophylaxis
預(yù)防Feline
Calici貓杯狀(FCV)(FCV)Etiology
病因clinical
signs
臨床癥狀DiagnosisTreatment
治療
Prophylaxis
預(yù)防Feline
Calici貓杯狀(FCV)(FCV)small,
unenveloped
RNA-with
cup-like
impressions小的,似杯狀的無衣殼RNAhighly
contagious
傳染性強infectious
up
to
3
weeks
in
the
environment在環(huán)境中3周仍有
性high
variability=>變異性強strains
with
high
pathogenicity
高致病性菌株ABCDEORF
15’3’ORF
35’HVRCons3’HVRFelineCalici貓杯狀(FCV)(FCV)ORF
2Excretion
排毒TransmissionTenacity穩(wěn)定性carrier
state帶毒狀態(tài)下by
oral
and
nasal
discharge,
saliva(few
days
up
to
life-long
period)從口腔和鼻
物,唾液(幾天到
)generally
direct,通常直接indirect
transmission
possible可能發(fā)生間接relatively
stable
in
theenvironment在環(huán)境中相對穩(wěn)定(可達3周)(up
to
3
weeks)replication
in
tonsills
andlymphoepithelial
tissuecontinuous
shedding在扁桃體和淋巴上皮組織中
不斷脫殼FCV
–
Epidemiology貓杯狀
-流行病學(xué)Carrierstatus
FCV貓杯狀
帶毒狀態(tài)elimination排毒chronic
shedder
慢性脫殼+susceptible
cat疑似病例40%colony
cats
40%群居貓
25%show
cats
25%純種貓
8%household
pets
8%家養(yǎng)貓
20%practice
cases
實踐案例cat
with
acute
FCV
infection急性FCV
的貓chronicSequelae慢性后遺癥clinicalRecovery臨床康復(fù)許many
cats
stillshedding30days
after
infection多貓30天后仍然排毒50%
cats
still
shedding75
days
post
infection50%的貓
后75天仍然排毒eliminatednon-carriers排毒后成為非攜帶者self-limiting自限性的or
life-long帶毒Carriers攜帶者Gaskell
&
Bennett,1996FCV
-carrierstateFeline
Calici貓杯狀(FCV)(FCV)Etiology
病因clinical
signs
臨床癥狀DiagnosisTreatment
治療
Prophylaxis
預(yù)防incubation
period潛伏期Signs
癥狀Nose
鼻Eyes
眼oral
口腔respiratory
tract呼吸道chronic
infections慢
染有時打噴嚏,
物+2-4
days
2-4天generally
milder
than
with
FHV通常比同時
FHV要輕sometimes
sneezing,
discharge
+usually
no
ocular
signs
通常沒有眼部癥狀big
vesicles,ulcers
大水泡,潰瘍rarely
p onia
罕見chronic
proliferative
stomatitis慢性增生性口炎Clinical
Signs臨床癥狀Clinical
Signs臨床癥狀Clinical
Signs臨床癥狀
/cpdvets/LimKitten
Syndrome
Pedersen
et
al.,
1983幼貓跛行綜合征Lmainly
in
kittens
of
6
-
12weeks主要在6-12周的幼貓Loften
after
vaccinations
常在免疫之后Lusually
intermittent,
often
with
fever一般是間歇性的,常伴發(fā)熱Lmostly
self-limiting
大多數(shù)是自限性的Lcertain
antigenic
variant?
確定有抗原變異?Lrelated
to
vaccine?免疫相關(guān)?L replication
in
joints?在關(guān)節(jié)嗎Limmune-mediated?免疫介導(dǎo)的?Lincreased
in
1-acid
glycoprotein?
-酸性糖蛋白升高Chronic
Proliferative
Stomatitis慢性增生性口炎Lchronic
慢性Lrecurrent
復(fù)發(fā)Lproliferative
增生Lulcerative
潰瘍Llymphocytic/plasmocytic淋巴細胞/漿細胞Limmune-mediated
reaction
to
chronicFCV
infection慢性FCV
的免疫介導(dǎo)效應(yīng)Lrole
of
chronic
carriers?慢性攜帶Lrole
of
FIV
and
FeLV?貓免疫缺陷者的作用和貓白血病
的作用in
some
studies
75
%
of
cases
of
chronic
stomatitis在某些研究結(jié)果中慢性口炎病例的75%hemorrhagic
syndrome(generalized
systemic
calicisyndrome)性綜合征(系統(tǒng)性杯狀
綜合征)Pedersen
et
al.,2000recently
described
syndrome最近此綜合征有被描述severe
?systemic
hemorrhagic
fever”嚴重的“系統(tǒng)性
熱”high
mortality,
mainly
older
cats率高,主要發(fā)生于老年貓no
protection
by
common
vaccines沒有常規(guī) 保護GSCVS系統(tǒng)性杯狀
綜合征LDSH
本地短毛貓L3
years
old
3歲Lmale
neutered
絕育公貓L
single
cat
household,
indoor
only家里只養(yǎng)了一只,室內(nèi)Lregularly
vaccinated,常規(guī)免疫complete
primo-vaccination,首次免疫完全last
vaccination
(HCP)最后一次免疫(貓三聯(lián))4months
ago4個月前“Moritz”“Moritz”History
病史Lsince
1
day
problems
to
urinate
1天前排尿有問題
L
stranguria
痛性尿淋漓Ltoday
anorectic
今天開始厭食physical
examination
體檢Llarge
and
tense
bladder大且緊張DiagnosisFLUTD
貓下泌綜合征“Moritz”Treatment
治療Lindwelling
catheter
內(nèi)置導(dǎo)尿管Lemptying
ofthe
bladder排空Lfluid
therapy
(incl.
electrolyte
replacement)輸液治療(包括,補充電解質(zhì))Lpain
medication
止痛藥follow-up
回訪L ng
better
shortlyafter
treatment治療后很快好轉(zhuǎn)
Lstarted
eating
開始進食
Lcatheter
left
in
placefor
24
hours導(dǎo)尿管留置24小時“Moritz”the
next
day
…第二天...“Moritz”物物new
problems
新問題Lfever
發(fā)熱Locular
discharge
眼Lnasal
discharge
鼻Lsneezing
噴嚏Lulcerations
on
the
tongue舌潰瘍Lulcerations
on
the
paws爪子上潰瘍?Moritz“Foto:
S.Unterer,
München?Moritz“Foto:
S.Unterer,
München“Tiger”“B?24
Hours
Later24小時之后“Tiger”“Moritz”???“B?rli”72
Hours
Later
…72小時后Feline
Calici貓杯狀(FCV)(FCV)Etiology
病因clinical
signs
臨床癥狀DiagnosisTreatment
治療
Prophylaxis
預(yù)防FCV
–
DiagnosisFCV-detection
of
antibodies抗體檢測-
PCR聚合酶鏈反應(yīng)detection
of
檢測- isolation
(cell
culture)分離(細胞培養(yǎng))not
useful
無效vaccination
免疫antigenic
variability抗原變異性sensitive
and
specific敏感且特異Specific
特異
sensitive?敏感?strain
differentiation亞型鑒別Feline
Calici貓杯狀(FCV)(FCV)Etiology
病因clinical
signs
臨床癥狀DiagnosisTreatment
治療
Prophylaxis
預(yù)防Supportive
Treatment支持療法fluid
therapy
輸液治療=>Rehydration
再水合(=>
amelioration
of
the
mukociliary
clearance)(改善粘液纖毛清除率)gesia
if
necessary需要時進行鎮(zhèn)痛Lvitamin
A維生素ALvitamin
C維生素CLvitamin
B
complex復(fù)合維生素B5000
IU/kg
PO
q
24
h5000IU/kg
口服每24h一次80
mg/kg
PO
q
8
h80mg/kg
口服每8h一次SC
q
48
h皮下每48h一次Supportive
Treatment支持療法vitamins
(mucosal
regeneration)維生素(黏膜再生)Supportive
Treatment支持療法nutritional
management
營養(yǎng)管理purée
and
warmed
food(microwave)果泥和熱水(微波)appetite
stimulation
刺激食欲diazepam
(Valium?)
0.05
-
0.25
mg/kg
IV(immediate
effect)
0.05-0.25mg/kg
靜注(即時效應(yīng))cyproheptadin
(Peritol?)
0.5
-
1
mg/kg
q
12
h
PO賽庚啶(Peritol
?)0.5-1mg/kg每12小時一次口服mirtazapine
3
mg/cat
PO
米氮平3mg/貓口服tube
feeding
if
necessary必要時可用飼喂管喂食Nasal
Tube鼻飼管Esophagal
Tube食道飼喂管effective
invitro體外作用controlledstudy
in
vivo體內(nèi)對照組effective
invivo體內(nèi)作用assessment
of
effectiveness(1
–
4)效果評估Immunglobulins免疫球蛋白Yes
有No
無Unknown未知possibly
effective
(4)有效率(4)Ribavirin
利巴韋林Yes
有jaNo
無too
toxic
systemically
(2),全身毒性強(2)possibly
as
aerosol(4)氣霧劑有效率(4)humaninterferon-α人用α-干擾素s.c.
high
dose皮下高劑量p.o.
low
dose口服低劑量Yes
有No
無Unknown未知Unknown未知possibly
effective
(4)有效率(4)Yes
有No
無probably
not
effective
(4)無效率(4)felineinterferon-ω貓ω-干擾素Yes
有No
無Unknown未知possibly
effective
(3)有效率(3)Antiviral
Chemotherapy抗
化療effective
invitro體外作用controlledstudy
in
vivo體內(nèi)對照組effective
invivo體內(nèi)作用assessment
of
effectiveness(1
–
4)效果評估Immunglobulins免疫球蛋白Yes
有No
無Unknown未知possibly
effective
(4)有效率(4)Ribavirin
利巴韋林Yes
有jaNo
無too
toxic
systemically
(2),全身毒性強(2)possibly
as
aerosol(4)氣霧劑有效率(4)humaninterferon-α人用α-干擾素s.c.
high
dose皮下高劑量p.o.
low
dose口服低劑量Yes
有No
無Unknown未知Unknown未知possibly
effective
(4)有效率(4)Yes
有No
無probably
not
effective
(4)無效率(4)felineinterferon-ω貓ω-干擾素Yes
有No
無Unknown未知possibly
effective
(3)有效率(3)Antiviral
Chemotherapy抗
化療Ribavirin利巴韋林commercially
available
e.g.
Ribazole?有商品化藥物,如Ribazole?antiviral
effects
抗
nucleoside效果ogue
(guanosine
derivative)核苷類似物(鳥苷衍生物)
interferes
with
DNA
and
mRNA
synthesis干擾DNA和mRNA的Dosage
劑量
11
mg/kg
q
24
h
PO
or
IV
(max.
7
days)11mg/kg
24h一 次
口服或靜注(最長7天)
only
in
combination
with
interferon-
orinliposomes?只能與a/w-干擾素或脂質(zhì)聯(lián)合使用side
effects
(already
in
therapeutic
dosage!)副作用(已經(jīng)在治療劑量中出現(xiàn))
myelosuppression,
hepatotoxicity骨髓抑制,肝毒性
diarrhea,
gastro-intestinal
ulcera腹瀉,胃腸道潰瘍Ribavirin:
Experimental
Study
(2)利巴韋林:實驗報告(2)ribavirin
(25
mg/kg
q
8
h
PO
for
10
days)利巴韋林(25mg/kg
每8h一次口服服用10天)1
day
or
4
days
after
exposition
(aerosol)
to
FCV在FCV中1到4天后(氣霧劑)=>clinical
signsmore
severe
臨床癥狀更嚴重=>severe
side
effects
副作用越劇烈Povey,
1978Immunglobulins免疫球蛋白commercially
available
in
Europe
(Feliserin?)在歐洲有商品化藥物(Feliserin?)antiviral
effects
effect
against
FCV?抗作用
抗FCV的效果neutralizing
antibodiesagainst
FCV,
FHV,
FPV中和FCV,FHC,FPV抗體Dosage
劑量
for
prophylaxis
1
injection
SC
(1
ml)皮下注射1次(1ml)預(yù)防
for
treatment
3
injektionen
SC
(1
ml)
q
24
hlokal
application?治療每24h一次皮下注射3支外用?side
effects
副作用
anaphylaktic
reaction
in
cats
(repeated
application)貓的過敏反應(yīng)(重復(fù)應(yīng)用時)human
interferon-,
feline
interferon-人用a-干擾素,貓w-干擾素antiviral
effects
抗
作用
inhibits抑制assemly
and
budding裝配和芽孢
cytokine,
immunomodulatory
effect細胞因子,免疫調(diào)節(jié)作用Dosage
劑量
huIFN-
high
dose
105
IU/kg
q
24
h
SQ
(short
term)人a-干擾素高劑量105
IU/kg
每24h
皮下(短期)
huIFN-
low
dose
1
(-50)
IU
q
24
h
PO
(long
term)人a-干擾素低劑量1(-50)IU
每24h
口服(長期)
feIFN-
106
IU/kg
S 24
h
on
5
consecutive
days貓w-干擾素
106
IU/kg
皮下每24h
連用5天side
effects
副作用
rarely
allergic
reactions
(huIFN-)少見過敏反應(yīng)(人a-干擾素)Interferon-ωΩ-干擾素Interferon-ωΩ-干擾素L
in
vitro
strain-dependent
efficacyTaira
et
al.,
2005,
Kyoko
et
al.,2008品種依賴型體外有效性no
controlled
clinical
studies沒有對照的臨床研究----multi-center
study
多中心研究no
FCV
diagnostics
沒有
FCVno
controls
沒有對照not
controlled,
all
cats
received
symptomatic
treatment所有貓接受對癥治療felines
interferon-ω
2.5
or
5
x
106
IU/kg
IV
q
24
h
for
3
daysimprovement
<
4
days
after
signs
had
appeared貓ω-干擾素
2.5
or
5
x
106
IU/kg
靜注每24h一次
3天出現(xiàn)臨床癥狀后4天之內(nèi)得到改善efficacy?有效?Interferon-ω
in
Acute
FCV
InfectionΩ-干擾素在急性FCV
中的應(yīng)用field
study(Japan)領(lǐng)域研究(Uhino
et
al.,
1997160
cats
with
URTD
or
stomatitis160只貓,上呼吸道疾病或口炎)Experimental
Drugs實驗性藥物-specific
antiviral
抗特異
藥物phosphorodiamidate
morpholino
oligomer磷酰二胺嗎啉代低聚物experimental
infection
實驗
染=>improved
survival
rate
提高存活率Smith
et
al.,
2008not
commercially
available
沒有商品化藥物Treatment
of
Chronic
Stomatitis慢性口炎的治療Interferon-ω
in
Chronic
Stomatitisω-干擾素在慢性口炎中的應(yīng)用lokale
treatment
with
interferon-Mihaljevic,
2003局部使用-干擾素sofar
no
placebo-controlled
studies(!)至今沒有可靠的對照研究feline
interferon-
2.5
x
106
IU/kginjection
of
several
depots
of
0.1
ml
(gingiva)
+
left
over
SQ貓w-干擾素2.5x106
IU/kg
0.1ml多點注射(牙齦)+剩余皮下treatment
repeated
if
necessary
必要時重復(fù)important:
proper
dental
surgeries
(!)重要的是:恰當(dāng)?shù)难揽剖中g(shù)efficacy
of
interferon-ω???ω-干擾素有效性???Treatment
of
Chronic
Stomatitis慢性口炎的治療prednisolone0,5
mg/kg
q
12
h
PO龍0.5mg/kg
每12h一次口服+cyclosporin
環(huán)孢菌素week
5
10
mg/kg
q
24
h
PO
for
5
days,
2-day
break,afterwards
5
mg/kg
q
12
h
PO
for
5
days,
2-day
break,after
that
5
mg/kg
q
12
h
PO
for
5
days,
2-day
break,etc.5周10mg/kg
每24h一次口服5天,停2天,之后5mg/kg
每12h一次口服5天,停2天,之后5mg/kg
每12h一次口服5天,停2天…Alternative
可選擇tooth
extraction
拔牙if
necessary
all
teeth!必要拔掉所有牙齒Treatment
of
Chronic
Stomatitis慢性口炎的治療Feline
Calici貓杯狀(FCV)(FCV)Etiology
病因clinical
signs
臨床癥狀DiagnosisTreatment
治療
Prophylaxis
預(yù)防Problems
with
Vaccination免疫帶來的問題no
complete
protection
against
disease對疾病沒有完全的保護性L only
against
developm
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年音樂作品委托創(chuàng)作合同改編
- 餐飲廢油回收合同范本
- 農(nóng)土租賃合同范本
- 購買茶葉協(xié)議合同范本
- 抗震配件銷售合同范本
- 養(yǎng)殖合作回收合同范本
- 2025裝修設(shè)計委托合同范本
- 2025成都市租房合同范本下載
- 2025年股權(quán)質(zhì)押借款合同模板
- 2025年xx村公益性項目購買材料詢價會議記錄
- 六年級下冊數(shù)學(xué)教案-比例 西師大版
- 卓有成效的管理知到課后答案智慧樹章節(jié)測試答案2025年春青島黃海學(xué)院
- 非遺藍染中國非遺文化藍染工藝介紹課件
- 抗日英雄人物楊靖宇介紹
- AI驅(qū)動的可持續(xù)能源發(fā)展
- 【博觀研究院】2025年跨境進口保健品市場分析報告
- 整本書閱讀《林海雪原》【知識精研】六年級語文下冊 (統(tǒng)編版五四制2024)
- 牛奶的工藝流程
- 土地勘測定界技術(shù)方案
- 健康日用品設(shè)計與研發(fā)趨勢
評論
0/150
提交評論